tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Andrew Galler, 16 are a BUY (59.26%), 2 are a SELL (7.41%), 9 are a HOLD (33.33%).
Analyst Andrew Galler, carries an average stock price target met ratio of 75.67% that have a potential upside of 20.5% achieved within 150 days. Previously, Andrew Galler worked at MORGAN STANLEY, WOLFE.
Andrew Galler’s has documented 57 price targets and ratings displayed on 9 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on IMCR, Immunocore Holdings Ltd at 07-Mar-2025.
Analyst best performing recommendations are on MRNA (MODERNA).
The best stock recommendation documented was for MRNA (MODERNA) at 11/8/2021. The price target of $304 was fulfilled within 18 days with a profit of $59.32 (24.24%) receiving and performance score of 13.47.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 27-Jan-2026
$14.5
$0.01 (0.07%)
$14.5
8 months 9 days ago
(19-Feb-2026)
5/16 (31.25%)
$0.15 (1.05%)
679
Buy Since 06-Sep-2024
$14.5
$0.01 (0.07%)
$18
9 months 6 days ago
(22-Jan-2026)
0/2 (0%)
$0.23 (1.61%)
Buy Since 24-Feb-2022
$14.5
$0.01 (0.07%)
$14
9 months 29 days ago
(29-Dec-2025)
7/11 (63.64%)
$0.25 (1.75%)
530
Buy Since 17-Dec-2025
$14.5
$0.01 (0.07%)
$17
10 months 6 days ago
(22-Dec-2025)
0/2 (0%)
$0.29 (2.04%)
Buy Since 19-Dec-2025
$14
10 months 9 days ago
(19-Dec-2025)
1/1 (100%)
$5.52 (65.09%)
92
